Skip to main content
. 2022 Apr 25;25(2):94–105. doi: 10.4048/jbc.2022.25.e17

Table 4. Pathologic nodal stages after neoadjuvant chemotherapy according to BpCR and clinical lymph nodal stage.

Clinical lymph node status Total ypN0 ypN1 ypN2
Number % Number % Number % Number %
BpCR 1,427
cN0 307 24.2 304 99.0 4 1.0 0 0.0
cN1 695 54.8 606 87.2 79 11.4 10 1.4
cN2 266 21.0 223 83.1 36 13.0 7 3.9
cN0-2 1,268* 1,133 88.7 118 9.6 17 1.6
Non-BpCR 5,147
cN0 1,229 28.8 972 79.1 223 18.2 34 2.7
cN1 2,267 52.2 791 34.9 1,148 50.6 328 14.5
cN2 765 19.0 242 31.6 293 38.3 230 30.1
cN0-2 4,261 2,055 48.2 1,664 39.0 592 13.8
Total
cN0 1,536 27.8 1,276 83.1 227 14.7 34 2.2
cN1 2,962 53.6 1,397 47.2 1,227 41.4 338 11.4
cN2 1,031 18.6 465 45.1 329 31.9 237 23.0
cN0-2 5,529 3,138 56.8 1,782 32.2 609 11.0

BpCR = breast pathologic complete response.

*Missing data, n = 159; Missing data, n = 886; Missing data, n = 1,045.